By company type

Life sciences

A life sciences claim can be large, long and technical, with subcontracted trials, grant funding and projects that run for years. The adviser's technical depth and the treatment of subcontracted costs matter as much as the rate.

What matters most about fees

Life sciences claims can be large and are technical: trials, formulation, assays, regulatory work, with costs spread between staff, subcontractors and collaborators, and projects that run across several accounting periods. The adviser's technical depth in your field matters, and so does their handling of subcontracted and grant-funded work; the country pages link to the official sources. On a large claim the fee ceiling matters, and so does review support, because a technical review of a life sciences claim can be long.

Key questions

Likely red flags

Uncapped success fees on a large claim. Review support costs extra with no budget, on a claim where a review would be long. No one speaks to your engineers, or in this sector your scientists. The fair versions exist: a claim that will stay small, a priced support clause you chose knowingly, a scientific lead who wrote the descriptions. The green flag named people with qualifications you can check is the one to look for first.

Fee models to compare

Fixed fees and capped fees suit a large claim with a known scope. Hybrid fees keep part of the fee tied to the outcome where the claim is uncertain. Hourly fees with a budget suit specific technical work. A contingent success fee can still suit an early stage company before revenue, where cash is the constraint; on the shared example it is $50,000 on a $250,000 claim and nothing if the claim fails. Illustrative figures. The preparing for adviser meetings guide covers bringing your scientific lead to the first meeting.

General information about choosing and managing an adviser. It is not advice on whether your work qualifies for R&D tax relief.